NOA-104 ameliorates atopic dermatitis in the preclinical setting
March 20, 2025
Atopic dermatitis (AD) is mainly triggered by immune dysregulation, barrier dysfunction and inflammation propagation, and chronic itching increases the susceptibility to infections.